Weighted Vests: A growing Fitness Trend – ‌But Are They Right For You?

ORLANDO, FL – Exercising with‌ a weighted vest is gaining popularity, offering potential benefits like ‌increased calorie burn and improved cardiovascular fitness.However, experts caution that while the vests can be effective, they aren’t suitable for everyone ​and carry potential risks.

The article‌ details how optic neuropathy,often ⁢linked ‌to glaucoma,isn’t ‌always caused ‌by increased intraocular pressure. For individuals with narrow angles in their eyes, a Laser Peripheral ⁤Iridotomy (LPI) -⁢ creating⁢ small laser-drilled holes in the iris – can definitely help fluid drain and prevent pressure buildup. ‌

Notably, ‍certain medications, including the antidepressant Zoloft (an SSRI), can ‍slightly increase the risk of angle closure in those with narrow⁤ angles, possibly leading to increased pressure and glaucoma. ⁣While cold/allergy medicines and anticholinergic drugs are more commonly ⁤associated with this issue, individuals on Zoloft should be vigilant for vision​ changes and promptly consult ⁣an eye doctor. Those who have undergone an LPI face a lower risk but should still‍ remain‍ aware of any visual disturbances.

In a seperate correction, Dr.Roach clarified the classification ​of ⁢Type 1 diabetes. He acknowledged a reader’s point that definitions vary by‌ country. Globally, a “rare” disease affects fewer than 1 in 2,000 peopel (or fewer than 200,000 in the U.S.), while ⁢a “common” disease affects 1% of the population or ⁣more. Type 1 diabetes, affecting roughly 0.5% of the population, is therefore considered “uncommon,” ⁤unlike Type 2 diabetes, which impacts about 6%.

Readers with health questions can⁢ email​ Dr.Roach at ⁣ToYourGoodHealth@med.cornell.edu or​ mail ⁣them to 628 Virginia Dr., orlando, ⁣FL 32803.

Understanding Recent Advances⁣ in Type 1 Diabetes ‍& Addressing Concerns About Dementia and Premature‌ Birth

Recent‌ advancements ⁣offer hope for⁣ individuals newly diagnosed with⁣ Type 1 diabetes. Emerging therapies have the‍ potential to help preserve the function‍ of insulin-producing cells⁤ in the pancreas, potentially⁣ reducing the amount of insulin a person‌ needs to manage⁢ their condition. It’s noteworthy that a⁣ notable number of healthcare professionals also live with Type 1 diabetes, demonstrating triumphant long-term management is possible. With consistent care⁣ and ‌attention, individuals ​can often ⁤avoid the serious complications associated with diabetes, such as kidney disease, vision loss, and nerve damage, for many years.

For anyone recently diagnosed, consulting with an endocrinologist specializing in Type 1 diabetes is the crucial‍ first​ step. Numerous support organizations exist, with the American diabetes Association being the largest and​ offering a⁤ complete website with valuable data.

Regarding Frontotemporal Dementia and Premature⁢ Birth:

A​ reader​ inquired about a potential ⁢link between frontotemporal ‍dementia‌ and premature birth. Their⁣ brother, born at 28 weeks gestation weighing 2 pounds, 4 ounces, and requiring extended incubator care, has ‍experienced frontal ⁤lobe‍ issues for over 15 years with⁤ worsening memory.

While premature birth is a known risk factor for ‌brain changes and cognitive impairment, often affecting the frontal and temporal lobes, it is considered distinct from frontotemporal‌ dementia.⁣ Frontotemporal dementia typically manifests in individuals in their 50s, ‍even after a period of⁤ normal progress and previously normal cognitive function. The⁤ risk associated with premature birth increases with earlier gestational age.

Contact Information:

Dr. Roach is unable to respond to individual inquiries directly but may address submitted questions within the column. ⁢Questions​ can‌ be emailed to ToYourGoodHealth@med.cornell.edu or mailed‌ to 628 Virginia dr.,Orlando,FL ‌32803.

© 2022​ North America Syndicate Inc. All Rights ‌Reserved.

(Disclaimer: This rewritten article‌ aims to preserve all verifiable facts ‍from⁣ the original text. It does⁣ not offer medical advice and should not be substituted for professional medical consultation.)

Bone Health Battle: Patient Questions Drug Side Effects

Experts Address Osteoporosis Treatment Concerns

A 74-year-old man grappling with severe osteoporosis is seeking clarity on potential medication side effects, particularly concerning blood pressure spikes and persistent infections. His journey through various treatments highlights the complexities of managing bone density loss.

Navigating Osteoporosis Medications

The patient, whose DEXA score indicates a -3.3 reading, has experienced significant health issues following his osteoporosis treatment. After a six-month period of infections while on Prolia (denosumab), his doctor prescribed Fosamax (alendronate). Subsequently, he recorded a blood pressure reading of 201/121 mmHg.

He discovered a Phase 4 clinical trial suggesting Fosamax can contribute to elevated blood pressure. However, his physician maintains that the drug does not cause hypertension. Uncertain about switching to other bisphosphonates due to fear of similar reactions, the patient is seeking guidance on the best course of action.

Understanding Fosamax and Blood Pressure

According to medical insights, a more accurate statement regarding Fosamax and blood pressure would note that individuals taking alendronate experience similar rates of hypertension development as those receiving a placebo. During a 12-month trial, 1.9% of participants on alendronate developed high blood pressure, a rate comparable to the placebo group.

While a direct causal link is unlikely, the possibility of a rare, uncharacterized reaction cannot be entirely dismissed. It is recommended that physicians report such potential adverse events.

Alternative Approaches for Severe Osteoporosis

A DEXA T-score of -3.3 signifies substantial osteoporosis. For such low readings, medications like denosumab (Prolia) or bisphosphonates, which inhibit bone resorption by osteoclasts, may not be the primary choice.

Prolia carries a theoretical risk of increased infections, which the patient may have experienced. A more suitable alternative could be a medication that stimulates bone growth, such as teriparatide.

Furthermore, it is advisable to screen men with osteoporosis for low testosterone levels, as this condition is a significant risk factor for bone loss. According to the National Osteoporosis Foundation, low testosterone can contribute to bone loss in men.

Microplastics in Medication and Daily Life

Concerns have also been raised about the potential buildup of microplastic particles from dissolvable capsules used in medications and supplements. Microplastics, tiny polymer fragments, have been detected in human blood and organs, primarily from contaminated food and water sources.

However, the capsules used for most medications are typically made from gelatin, a plant protein, starch, or other plant-based materials, not plastic. Very few exceptions exist where the capsule shell is not intended for absorption and is excreted intact.

Therefore, medication capsules are generally not considered a significant source of microplastic intake. To reduce microplastic consumption, individuals are advised to drink tap water instead of bottled water, as bottled water often contains significantly higher levels of microplastics.

Coronary Calcium Scores: Magnesium’s Role Questioned, Exercise Benefits Bone Health

A high coronary calcium score, even with low cholesterol, signals increased heart attack risk. While magnesium supplements are sometimes recommended, their effectiveness is debated. Meanwhile, targeted exercise shows promise for strengthening bones in those with osteoporosis.

Magnesium and Heart Health: A Complex Picture

For individuals with elevated coronary calcium scores, a common concern is reducing this calcification. A reader inquired about magnesium supplements for this purpose, in addition to standard treatments like aspirin and statins. Coronary calcium scores measure calcification in heart arteries, acting as a predictor for potential blockages and heart attacks.

While some studies suggest a link between higher magnesium intake and reduced heart disease risk, the evidence is not definitive. It’s challenging to isolate magnesium’s impact, as individuals with higher magnesium levels often consume healthier diets overall. This makes it difficult to ascertain if the benefit comes directly from magnesium or other dietary factors.

To establish a clear cause-and-effect relationship, large-scale clinical trials are needed. These would involve comparing groups receiving magnesium supplements against those receiving a placebo. However, such trials are complex, time-consuming, and costly, and have not yet been conducted for magnesium in this specific context.

For those already diagnosed with coronary calcium, increasing their risk for heart attack, studies on magnesium supplementation have yielded inconsistent results in preventing heart attacks. This contrasts with statins, which have consistently demonstrated a reduction in heart attack rates for individuals with known arterial blockages or high cardiovascular risk, regardless of cholesterol levels.

It’s important to note that low cholesterol does not eliminate heart disease risk; approximately 30% of individuals with coronary disease have normal cholesterol levels. Therefore, a comprehensive assessment of cardiovascular risk, considering various factors beyond just cholesterol, is crucial.

Osteoporosis and Exercise: Building Stronger Bones

Another reader, undergoing treatment for osteoporosis with some improvement from medication, asked about the efficacy of specialized exercise programs in strengthening bones. For years, the prevailing advice emphasized high-impact, weight-bearing exercises for fracture prevention in osteoporosis patients.

However, recent research suggests that the intensity of impact may not be the sole determining factor. Current recommendations often advise individuals to choose activities they enjoy and will consistently perform. Walking, for instance, is a widely accessible and beneficial form of exercise. Incorporating stretching or weightlifting can offer additional advantages for bone health.

Concerns have been raised regarding vibration machines, but evidence supporting their effectiveness in strengthening bones remains inconclusive. Experts currently do not recommend their use for this purpose. A meta-analysis published in the *Journal of Bone and Mineral Research* in 2022 found that while exercise is beneficial for bone density, the specific benefits of whole-body vibration for bone health in postmenopausal women are still under investigation, with varying results across studies.

Mammogram Letters Spark Breast Density Concerns

Understanding screening options and risk factors is vital for women’s health.

Following a 3-D mammogram, some women are receiving letters regarding the limitations of mammograms in detecting cancer within dense breast tissue, prompting questions about additional screening and individual risk assessment. What are the options, and who should pursue them?

Navigating Dense Breast Tissue Information

After receiving a concerning letter, one patient, identified as **R.W.**, sought clarity on the best course of action, given the challenges of self-exams due to the presence of cysts. Screening options mentioned include blood tests for biomarkers, MRIs, and ultrasounds. However, **R.W.** noted feeling the need to advocate for herself, as insurance recommendations might only cover the minimum.

Expert Insight on Breast Density and Screening

According to medical experts, dense breast tissue is a recognized risk factor, making it more difficult to detect developing cancers via mammography. About half of women undergoing mammograms are found to have dense breasts. While increased breast density is not an abnormality, digital breast tomosynthesis, or 3-D mammography, offers superior imaging compared to traditional digital mammograms.

Assessing Individual Risk

Determining the most appropriate breast screening method requires an understanding of individual risk factors. A lifetime risk exceeding 20% is classified as high, while 15% to 20% is considered intermediate, and less than 15% is deemed average or low. The National Cancer Institute provides a tool to help estimate risk at BCRiskTool.cancer.gov. A family history of prostate cancer, however, does not significantly elevate breast cancer risk.

The Role of Mammography

Mammography remains the most extensively studied imaging tool. Multiple trials show that it reduces the risk of breast cancer deaths through early detection, allowing for timely removal before the cancer spreads. Evidence is strongest for women between 50 and 74; screening between ages 40-50 and after 74 is more controversial. Recognizing the risk of false positives, many women opt to begin screening between 40 and 45. Women over 75 should only be screened if they are in otherwise good health.

Alternative Screening Options

Given the limitations of mammograms, other imaging studies have been explored. MRI offers the highest sensitivity but carries a higher risk of false positives, ranging from 8% to 13% in optimal scenarios. Consequently, MRI is primarily recommended for individuals at high risk of breast cancer (greater than 20%).

For women with intermediate risk and dense breast tissue, a sonogram (ultrasound) is a reasonable supplement to 3-D mammography. For those with average or low risk, ultrasound may be offered but not insisted upon.

The Future of Biomarker Screening

While blood tests for biomarkers hold promise for future screening, they are not currently recommended outside of clinical trials. Moreover, numerous studies have not demonstrated a benefit from self-exams, though some expert examiners may find them beneficial. However, the presence of cysts can complicate interpretation.

Rising Breast Cancer Incidence

The American Cancer Society estimates that about 297,790 new cases of invasive breast cancer will be diagnosed in women in the United States in 2023 (American Cancer Society). Given the rising incidence, proactive discussion with healthcare providers regarding personalized screening strategies is crucial.